25 XP   0   0   10

HLS Therapeutics Inc
Buy, Hold or Sell?

Let's analyse HLS Therapeutics Inc together

PenkeI guess you are interested in HLS Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of HLS Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about HLS Therapeutics Inc

I send you an email if I find something interesting about HLS Therapeutics Inc.

Quick analysis of HLS Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of HLS Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
C$0.15
When do you have the money?
1 year
How often do you get paid?
65.0%

What is your share worth?

Current worth
C$4.20
Expected worth in 1 year
C$3.09
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
C$-0.91
Return On Investment
-18.5%

For what price can you sell your share?

Current Price per Share
C$4.92
Expected price per share
C$3.52 - C$5.52
How sure are you?
50%

1. Valuation of HLS Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

C$4.92

Intrinsic Value Per Share

C$3.72 - C$5.88

Total Value Per Share

C$7.92 - C$10.08

2. Growth of HLS Therapeutics Inc (5 min.)




Is HLS Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$97.6m$140m-$32.5m-30.3%

How much money is HLS Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.8m-$5.8m-$983k-14.3%
Net Profit Margin-43.5%-38.2%--

How much money comes from the company's main activities?

3. Financial Health of HLS Therapeutics Inc (5 min.)




What can you expect buying and holding a share of HLS Therapeutics Inc? (5 min.)

Welcome investor! HLS Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of HLS Therapeutics Inc.

What can you expect buying and holding a share of HLS Therapeutics Inc?

First you should know what it really means to hold a share of HLS Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of HLS Therapeutics Inc is C$4.92. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of HLS Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in HLS Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$4.20. Based on the TTM, the Book Value Change Per Share is C$-0.28 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of HLS Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.17-3.4%-0.21-4.3%-0.18-3.7%-0.15-3.1%-0.09-1.9%
Usd Book Value Change Per Share-0.11-2.3%-0.20-4.1%-0.27-5.5%-0.10-1.9%0.040.9%
Usd Dividend Per Share0.000.0%0.040.8%0.040.8%0.040.7%0.020.5%
Usd Total Gains Per Share-0.11-2.3%-0.17-3.4%-0.23-4.7%-0.06-1.2%0.071.4%
Usd Price Per Share2.87-3.82-8.39-10.06-6.58-
Price to Earnings Ratio-4.25--4.61--13.42-14.47--10.28-
Price-to-Total Gains Ratio-25.91--23.87--232.46--115.96--80.41-
Price to Book Ratio0.94-1.14-1.93-2.07-1.88-
Price-to-Total Gains Ratio-25.91--23.87--232.46--115.96--80.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.573888
Number of shares279
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.04
Usd Book Value Change Per Share-0.20-0.10
Usd Total Gains Per Share-0.17-0.06
Gains per Quarter (279 shares)-46.04-16.35
Gains per Year (279 shares)-184.17-65.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
141-226-19441-107-75
283-451-37882-213-140
3124-677-562124-320-205
4166-903-746165-426-270
5207-1128-930206-533-335
6249-1354-1114247-639-400
7290-1580-1298288-746-465
8332-1805-1482329-852-530
9373-2031-1666371-959-595
10415-2257-1850412-1066-660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%6.034.00.015.0%61.046.00.057.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%15.025.00.037.5%50.045.012.046.7%
Dividend per Share3.00.01.075.0%11.00.01.091.7%19.00.01.095.0%26.00.014.065.0%60.00.047.056.1%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%15.025.00.037.5%65.037.05.060.7%

Fundamentals of HLS Therapeutics Inc

About HLS Therapeutics Inc

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.

Fundamental data was last updated by Penke on 2024-04-10 06:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of HLS Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit HLS Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare HLS Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -34.0% means that $-0.34 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of HLS Therapeutics Inc:

  • The MRQ is -34.0%. The company is making a huge loss. -2
  • The TTM is -43.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-34.0%TTM-43.5%+9.4%
TTM-43.5%YOY-38.2%-5.3%
TTM-43.5%5Y-33.2%-10.2%
5Y-33.2%10Y-19.3%-13.9%
1.1.2. Return on Assets

Shows how efficient HLS Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare HLS Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Assets means that HLS Therapeutics Inc generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of HLS Therapeutics Inc:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-3.1%+0.5%
TTM-3.1%YOY-2.3%-0.8%
TTM-3.1%5Y-1.9%-1.2%
5Y-1.9%10Y-0.9%-1.0%
1.1.3. Return on Equity

Shows how efficient HLS Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare HLS Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -5.5% Return on Equity means HLS Therapeutics Inc generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of HLS Therapeutics Inc:

  • The MRQ is -5.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.5%TTM-6.4%+0.9%
TTM-6.4%YOY-4.3%-2.1%
TTM-6.4%5Y-3.5%-2.9%
5Y-3.5%10Y-1.8%-1.8%

1.2. Operating Efficiency of HLS Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient HLS Therapeutics Inc is operating .

  • Measures how much profit HLS Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare HLS Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of HLS Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-9.9%+9.9%
TTM-9.9%YOY-21.8%+11.9%
TTM-9.9%5Y-14.0%+4.1%
5Y-14.0%10Y-2.8%-11.1%
1.2.2. Operating Ratio

Measures how efficient HLS Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.23 means that the operating costs are $1.23 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of HLS Therapeutics Inc:

  • The MRQ is 1.229. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.261. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.229TTM1.261-0.031
TTM1.261YOY1.219+0.042
TTM1.2615Y1.177+0.084
5Y1.17710Y0.772+0.405

1.3. Liquidity of HLS Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if HLS Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.65 means the company has $1.65 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of HLS Therapeutics Inc:

  • The MRQ is 1.652. The company is able to pay all its short-term debts. +1
  • The TTM is 1.575. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.652TTM1.575+0.077
TTM1.575YOY1.421+0.154
TTM1.5755Y1.448+0.127
5Y1.44810Y16.776-15.328
1.3.2. Quick Ratio

Measures if HLS Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare HLS Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.36 means the company can pay off $0.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of HLS Therapeutics Inc:

  • The MRQ is 0.361. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.920. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.361TTM0.920-0.559
TTM0.920YOY1.028-0.108
TTM0.9205Y1.076-0.156
5Y1.07610Y16.479-15.403

1.4. Solvency of HLS Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of HLS Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare HLS Therapeutics Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.53 means that HLS Therapeutics Inc assets are financed with 53.3% credit (debt) and the remaining percentage (100% - 53.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of HLS Therapeutics Inc:

  • The MRQ is 0.533. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.515. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.533TTM0.515+0.018
TTM0.515YOY0.457+0.058
TTM0.5155Y0.455+0.060
5Y0.45510Y0.324+0.131
1.4.2. Debt to Equity Ratio

Measures if HLS Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare HLS Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 114.0% means that company has $1.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of HLS Therapeutics Inc:

  • The MRQ is 1.140. The company is able to pay all its debts with equity. +1
  • The TTM is 1.065. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.140TTM1.065+0.075
TTM1.065YOY0.845+0.220
TTM1.0655Y0.845+0.220
5Y0.84510Y0.592+0.252

2. Market Valuation of HLS Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings HLS Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare HLS Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.25 means the investor is paying $-4.25 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of HLS Therapeutics Inc:

  • The EOD is -5.291. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.248. Based on the earnings, the company is expensive. -2
  • The TTM is -4.614. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.291MRQ-4.248-1.043
MRQ-4.248TTM-4.614+0.366
TTM-4.614YOY-13.421+8.807
TTM-4.6145Y14.466-19.080
5Y14.46610Y-10.283+24.749
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of HLS Therapeutics Inc:

  • The EOD is 7.682. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.168. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.551. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.682MRQ6.168+1.515
MRQ6.168TTM8.551-2.383
TTM8.551YOY11.013-2.462
TTM8.5515Y8.942-0.391
5Y8.94210Y-14.756+23.698
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of HLS Therapeutics Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of HLS Therapeutics Inc:

  • The EOD is 1.170. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.939. Based on the equity, the company is cheap. +2
  • The TTM is 1.136. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.170MRQ0.939+0.231
MRQ0.939TTM1.136-0.197
TTM1.136YOY1.927-0.790
TTM1.1365Y2.072-0.936
5Y2.07210Y1.882+0.191
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of HLS Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.152-0.278+83%-0.374+146%-0.131-14%0.061-348%
Book Value Per Share--4.2054.592-8%5.941-29%6.451-35%4.704-11%
Current Ratio--1.6521.575+5%1.421+16%1.448+14%16.776-90%
Debt To Asset Ratio--0.5330.515+3%0.457+17%0.455+17%0.324+64%
Debt To Equity Ratio--1.1401.065+7%0.845+35%0.845+35%0.592+92%
Dividend Per Share---0.051-100%0.053-100%0.051-100%0.032-100%
Eps---0.232-0.294+27%-0.250+8%-0.209-10%-0.127-45%
Free Cash Flow Per Share--0.1600.167-4%0.072+122%0.046+246%0.118+36%
Free Cash Flow To Equity Per Share---0.007-0.059+724%-0.001-91%0.035-120%0.039-118%
Gross Profit Margin--1.0001.207-17%1.834-45%0.527+90%0.740+35%
Intrinsic Value_10Y_max--5.878--------
Intrinsic Value_10Y_min--3.718--------
Intrinsic Value_1Y_max--0.503--------
Intrinsic Value_1Y_min--0.457--------
Intrinsic Value_3Y_max--1.578--------
Intrinsic Value_3Y_min--1.308--------
Intrinsic Value_5Y_max--2.731--------
Intrinsic Value_5Y_min--2.082--------
Market Cap157052796.000+20%126320818.300169264333.575-25%374940144.633-66%452302941.447-72%294199701.998-57%
Net Profit Margin---0.340-0.435+28%-0.382+12%-0.332-2%-0.193-43%
Operating Margin----0.0990%-0.2180%-0.1400%-0.0280%
Operating Ratio--1.2291.261-2%1.219+1%1.177+4%0.772+59%
Pb Ratio1.170+20%0.9391.136-17%1.927-51%2.072-55%1.882-50%
Pe Ratio-5.291-25%-4.248-4.614+9%-13.421+216%14.466-129%-10.283+142%
Price Per Share4.920+20%3.9505.253-25%11.555-66%13.853-71%9.058-56%
Price To Free Cash Flow Ratio7.682+20%6.1688.551-28%11.013-44%8.942-31%-14.756+339%
Price To Total Gains Ratio-32.275-25%-25.912-23.873-8%-232.462+797%-115.965+348%-80.407+210%
Quick Ratio--0.3610.920-61%1.028-65%1.076-66%16.479-98%
Return On Assets---0.026-0.031+20%-0.023-11%-0.019-27%-0.009-65%
Return On Equity---0.055-0.064+16%-0.043-23%-0.035-36%-0.018-68%
Total Gains Per Share---0.152-0.227+49%-0.322+111%-0.081-47%0.094-263%
Usd Book Value--97679117.541107436831.162-9%140022365.614-30%152255576.037-36%110400791.140-12%
Usd Book Value Change Per Share---0.111-0.202+83%-0.272+146%-0.095-14%0.045-348%
Usd Book Value Per Share--3.0543.335-8%4.315-29%4.686-35%3.417-11%
Usd Dividend Per Share---0.037-100%0.038-100%0.037-100%0.023-100%
Usd Eps---0.169-0.214+27%-0.182+8%-0.152-10%-0.092-45%
Usd Free Cash Flow--3719319.0913899286.144-5%1698189.107+119%1126093.842+230%2755663.552+35%
Usd Free Cash Flow Per Share--0.1160.121-4%0.052+122%0.034+246%0.085+36%
Usd Free Cash Flow To Equity Per Share---0.005-0.043+724%0.000-91%0.026-120%0.028-118%
Usd Market Cap114083151.014+20%91759442.413122953611.909-25%272356521.061-66%328552856.667-72%213706663.532-57%
Usd Price Per Share3.574+20%2.8693.815-25%8.394-66%10.063-71%6.580-56%
Usd Profit---5400011.401-6881490.181+27%-5898420.156+9%-4955542.771-8%-2996475.245-45%
Usd Revenue--15860096.43615765613.734+1%15363937.270+3%14738251.817+8%12651214.806+25%
Usd Total Gains Per Share---0.111-0.165+49%-0.234+111%-0.059-47%0.068-263%
 EOD+4 -4MRQTTM+18 -17YOY+17 -185Y+11 -2410Y+8 -27

3.2. Fundamental Score

Let's check the fundamental score of HLS Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.291
Price to Book Ratio (EOD)Between0-11.170
Net Profit Margin (MRQ)Greater than0-0.340
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.361
Current Ratio (MRQ)Greater than11.652
Debt to Asset Ratio (MRQ)Less than10.533
Debt to Equity Ratio (MRQ)Less than11.140
Return on Equity (MRQ)Greater than0.15-0.055
Return on Assets (MRQ)Greater than0.05-0.026
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of HLS Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.270
Ma 20Greater thanMa 504.392
Ma 50Greater thanMa 1004.225
Ma 100Greater thanMa 2004.035
OpenGreater thanClose4.900
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets209,060
Total Liabilities111,363
Total Stockholder Equity97,697
 As reported
Total Liabilities 111,363
Total Stockholder Equity+ 97,697
Total Assets = 209,060

Assets

Total Assets209,060
Total Current Assets44,095
Long-term Assets164,965
Total Current Assets
Cash And Cash Equivalents 21,952
Net Receivables 9,640
Inventory 9,534
Total Current Assets  (as reported)44,095
Total Current Assets  (calculated)41,126
+/- 2,969
Long-term Assets
Property Plant Equipment 965
Intangible Assets 162,344
Long-term Assets Other 619
Long-term Assets  (as reported)164,965
Long-term Assets  (calculated)163,928
+/- 1,037

Liabilities & Shareholders' Equity

Total Current Liabilities26,688
Long-term Liabilities84,675
Total Stockholder Equity97,697
Total Current Liabilities
Short Long Term Debt 4,692
Accounts payable 14,107
Other Current Liabilities 1,720
Total Current Liabilities  (as reported)26,688
Total Current Liabilities  (calculated)20,519
+/- 6,169
Long-term Liabilities
Long term Debt 82,045
Capital Lease Obligations Min Short Term Debt884
Long-term Liabilities Other 1,768
Long-term Liabilities  (as reported)84,675
Long-term Liabilities  (calculated)84,697
+/- 22
Total Stockholder Equity
Total Stockholder Equity (as reported)97,697
Total Stockholder Equity (calculated)0
+/- 97,697
Other
Capital Stock262,127
Common Stock Shares Outstanding 31,980
Net Debt 64,785
Net Invested Capital 184,434
Net Working Capital 17,407
Property Plant and Equipment Gross 3,085



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-09-301997-06-301997-03-31
> Total Assets 
0
0
0
0
0
0
27,816
0
0
0
37,561
0
0
0
25,576
22,959
32,751
32,125
30,373
27,472
29,175
28,709
28,636
42,513
42,860
42,446
41,491
42,623
40,681
39,770
29,979
29,149
30,336
34,142
44,195
45,442
48,088
46,668
49,245
52,762
55,478
61,323
77,992
73,168
77,473
69,653
45,862
42,516
48,799
50,649
53,438
47,972
52,990
47,123
45,403
47,185
45,995
41,926
46,010
46,778
53,067
61,377
49,679
49,336
50,226
52,306
54,815
54,208
60,553
62,149
60,170
45,273
43,045
28,048
26,599
27,223
27,001
26,410
25,524
25,401
25,841
26,945
384,646
385,847
368,058
322,799
306,425
299,820
334,718
323,358
319,671
306,408
291,833
305,992
303,906
296,732
296,104
283,913
275,905
270,524
266,628
250,335
241,652
234,155
226,818
215,228
209,060
209,060215,228226,818234,155241,652250,335266,628270,524275,905283,913296,104296,732303,906305,992291,833306,408319,671323,358334,718299,820306,425322,799368,058385,847384,64626,94525,84125,40125,52426,41027,00127,22326,59928,04843,04545,27360,17062,14960,55354,20854,81552,30650,22649,33649,67961,37753,06746,77846,01041,92645,99547,18545,40347,12352,99047,97253,43850,64948,79942,51645,86269,65377,47373,16877,99261,32355,47852,76249,24546,66848,08845,44244,19534,14230,33629,14929,97939,77040,68142,62341,49142,44642,86042,51328,63628,70929,17527,47230,37332,12532,75122,95925,57600037,56100027,816000000
   > Total Current Assets 
0
0
0
0
0
0
10,918
0
0
0
16,018
0
0
0
10,072
8,297
17,814
18,453
17,168
14,411
15,662
15,438
15,552
15,132
15,603
15,461
15,540
17,533
16,441
15,900
14,814
14,847
15,475
18,289
26,715
18,155
20,040
14,401
16,120
19,405
20,048
19,990
32,008
25,284
28,115
21,955
19,189
16,538
21,459
21,023
24,984
22,471
29,658
25,757
24,206
27,778
27,582
25,397
30,679
31,980
39,484
49,236
39,244
40,700
43,351
46,979
49,450
49,953
56,699
58,910
59,581
44,768
42,691
27,764
26,453
27,067
26,855
26,272
25,501
25,381
25,823
26,926
65,036
69,533
66,605
32,395
31,618
28,973
66,859
64,649
63,100
66,524
58,090
46,930
45,911
46,890
47,287
46,075
43,751
43,923
44,974
45,591
44,374
45,043
45,665
43,453
44,095
44,09543,45345,66545,04344,37445,59144,97443,92343,75146,07547,28746,89045,91146,93058,09066,52463,10064,64966,85928,97331,61832,39566,60569,53365,03626,92625,82325,38125,50126,27226,85527,06726,45327,76442,69144,76859,58158,91056,69949,95349,45046,97943,35140,70039,24449,23639,48431,98030,67925,39727,58227,77824,20625,75729,65822,47124,98421,02321,45916,53819,18921,95528,11525,28432,00819,99020,04819,40516,12014,40120,04018,15526,71518,28915,47514,84714,81415,90016,44117,53315,54015,46115,60315,13215,55215,43815,66214,41117,16818,45317,8148,29710,07200016,01800010,918000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
2,730
0
0
0
138
0
0
0
3,298
3,801
12,960
13,155
12,226
9,272
10,744
10,665
11,631
1,374
2,041
0
3,030
5,470
3,898
1,777
828
543
858
0
8,832
2,001
462
1,196
0
0
0
816
15,779
8,306
8,065
2,325
5,025
4,515
2,844
3,806
4,844
2,701
7,840
6,358
10,322
12,386
12,483
9,831
14,472
14,114
14,763
23,918
25,091
27,215
29,874
33,776
33,718
35,964
37,909
39,246
46,938
43,874
41,505
26,629
25,264
25,818
25,408
25,933
25,146
24,928
24,975
26,274
36,219
53,825
45,237
9,907
10,930
12,812
52,308
51,343
47,078
41,649
33,662
20,890
20,612
23,203
21,347
21,736
21,179
22,664
21,160
21,279
20,723
21,214
20,932
21,808
21,952
21,95221,80820,93221,21420,72321,27921,16022,66421,17921,73621,34723,20320,61220,89033,66241,64947,07851,34352,30812,81210,9309,90745,23753,82536,21926,27424,97524,92825,14625,93325,40825,81825,26426,62941,50543,87446,93839,24637,90935,96433,71833,77629,87427,21525,09123,91814,76314,11414,4729,83112,48312,38610,3226,3587,8402,7014,8443,8062,8444,5155,0252,3258,0658,30615,7798160001,1964622,0018,83208585438281,7773,8985,4703,03002,0411,37411,63110,66510,7449,27212,22613,15512,9603,8013,2980001380002,730000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
473
173
172
172
180
172
174
167
0
0
153
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000000000000000000000153001671741721801721721734730000000000000000
       Net Receivables 
0
0
0
0
0
0
6,109
0
0
0
10,702
0
0
0
3,579
3,383
3,414
4,292
3,592
3,784
3,369
3,380
2,294
11,695
11,587
13,206
10,082
9,117
9,293
10,182
10,051
10,432
10,414
13,925
13,960
12,501
16,232
10,067
12,862
16,127
16,589
15,264
12,686
13,404
16,153
15,795
11,033
7,605
15,110
13,336
16,673
16,311
18,176
16,548
11,456
13,930
13,359
14,183
14,394
15,491
20,372
21,120
13,120
12,319
12,106
12,043
14,859
13,184
17,613
18,737
12,120
820
936
980
1,086
1,119
1,205
175
242
362
583
447
25,846
13,057
17,711
19,012
17,509
13,344
11,075
9,618
11,858
13,477
10,545
12,535
12,497
11,135
12,867
12,002
11,511
10,670
10,982
10,334
11,194
10,154
12,068
9,556
9,640
9,6409,55612,06810,15411,19410,33410,98210,67011,51112,00212,86711,13512,49712,53510,54513,47711,8589,61811,07513,34417,50919,01217,71113,05725,8464475833622421751,2051,1191,08698093682012,12018,73717,61313,18414,85912,04312,10612,31913,12021,12020,37215,49114,39414,18313,35913,93011,45616,54818,17616,31116,67313,33615,1107,60511,03315,79516,15313,40412,68615,26416,58916,12712,86210,06716,23212,50113,96013,92510,41410,43210,05110,1829,2939,11710,08213,20611,58711,6952,2943,3803,3693,7843,5924,2923,4143,3833,57900010,7020006,109000000
       Other Current Assets 
0
0
0
0
0
0
455
0
0
0
3,107
0
0
0
3,194
1,113
966
832
1,178
1,184
1,369
1,221
1,454
1,582
1,722
1,954
2,074
2,762
3,165
3,832
3,781
3,740
4,139
4,277
3,823
3,561
3,253
3,092
3,176
3,278
3,459
3,910
3,543
3,574
3,896
3,835
3,131
1,228
3,505
3,881
3,468
3,460
3,642
2,851
2,428
1,462
1,741
1,382
1,270
1,606
1,594
1,580
1,033
1,166
1,371
1,160
873
805
1,177
926
522
74
250
156
103
130
242
164
113
90
265
206
1,617
1,563
1,762
1,484
1,674
1,257
1,645
1,853
2,109
2,708
2,824
2,359
2,172
2,347
3,010
5,529
4,520
5,599
5,637
6,420
3,555
2,966
2,700
2,174
0
02,1742,7002,9663,5556,4205,6375,5994,5205,5293,0102,3472,1722,3592,8242,7082,1091,8531,6451,2571,6741,4841,7621,5631,61720626590113164242130103156250745229261,1778058731,1601,3711,1661,0331,5801,5941,6061,2701,3821,7411,4622,4282,8513,6423,4603,4683,8813,5051,2283,1313,8353,8963,5743,5433,9103,4593,2783,1763,0923,2533,5613,8234,2774,1393,7403,7813,8323,1652,7622,0741,9541,7221,5821,4541,2211,3691,1841,1788329661,1133,1940003,107000455000000
   > Long-term Assets 
0
0
0
0
0
0
16,897
0
0
0
21,542
0
0
0
15,504
14,662
14,937
13,672
13,205
13,060
13,513
13,272
13,084
27,381
27,257
26,985
25,951
25,090
24,239
23,870
15,165
14,302
14,861
15,853
17,480
27,287
28,048
32,267
33,125
33,356
35,430
41,333
45,983
47,884
49,358
47,698
26,673
25,978
27,340
29,627
28,454
25,501
23,333
21,366
21,197
19,407
18,413
16,530
15,331
14,798
13,583
12,140
10,435
8,636
6,875
5,327
5,365
4,255
3,853
3,240
589
505
354
284
146
156
146
138
23
20
18
19
319,610
316,314
301,453
290,404
274,807
270,847
267,859
258,709
256,571
239,884
233,743
259,062
257,995
249,842
248,817
237,838
232,154
226,601
221,654
204,744
197,278
189,112
181,153
171,775
164,965
164,965171,775181,153189,112197,278204,744221,654226,601232,154237,838248,817249,842257,995259,062233,743239,884256,571258,709267,859270,847274,807290,404301,453316,314319,610191820231381461561462843545055893,2403,8534,2555,3655,3276,8758,63610,43512,14013,58314,79815,33116,53018,41319,40721,19721,36623,33325,50128,45429,62727,34025,97826,67347,69849,35847,88445,98341,33335,43033,35633,12532,26728,04827,28717,48015,85314,86114,30215,16523,87024,23925,09025,95126,98527,25727,38113,08413,27213,51313,06013,20513,67214,93714,66215,50400021,54200016,897000000
       Property Plant Equipment 
0
0
0
0
0
0
7,019
0
0
0
10,495
0
0
0
5,243
4,853
4,816
4,521
4,813
4,195
4,764
4,319
4,232
7,923
7,391
7,261
7,311
6,785
6,200
5,558
5,808
4,933
5,240
4,465
6,750
15,750
13,335
14,392
14,816
14,899
15,795
20,292
24,315
26,092
28,303
27,643
26,044
25,298
26,226
27,361
26,628
23,740
21,433
20,423
20,251
18,592
17,669
15,905
15,052
14,310
12,962
12,065
10,376
8,636
6,875
5,327
4,157
3,056
2,160
1,108
0
0
0
0
0
0
0
0
0
0
0
0
441
421
429
391
363
1,288
1,210
1,307
1,276
1,154
1,249
1,328
1,384
1,263
1,172
1,205
1,569
1,433
1,294
1,266
1,127
936
1,059
1,101
965
9651,1011,0599361,1271,2661,2941,4331,5691,2051,1721,2631,3841,3281,2491,1541,2761,3071,2101,2883633914294214410000000000001,1082,1603,0564,1575,3276,8758,63610,37612,06512,96214,31015,05215,90517,66918,59220,25120,42321,43323,74026,62827,36126,22625,29826,04427,64328,30326,09224,31520,29215,79514,89914,81614,39213,33515,7506,7504,4655,2404,9335,8085,5586,2006,7857,3117,2617,3917,9234,2324,3194,7644,1954,8134,5214,8164,8535,24300010,4950007,019000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,106
8,075
8,449
8,431
8,077
8,161
8,844
9,482
9,506
9,146
9,249
8,893
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000008,8939,2499,1469,5069,4828,8448,1618,0778,4318,4498,0758,1060000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
9,099
0
0
0
9,873
0
0
0
6,533
0
0
0
0
0
0
0
5,980
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
312,659
300,396
289,463
286,729
271,153
266,343
263,378
254,189
252,050
235,669
229,465
254,705
253,404
247,612
246,737
235,894
229,181
223,282
217,857
202,267
195,018
186,984
178,802
168,867
162,344
162,344168,867178,802186,984195,018202,267217,857223,282229,181235,894246,737247,612253,404254,705229,465235,669252,050254,189263,378266,343271,153286,729289,463300,396312,659000000000000000000000000000000000000000000000000000000000005,98000000006,5330009,8730009,099000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,561
3,284
3,291
3,216
3,271
3,213
3,245
3,061
3,029
3,029
3,207
967
908
739
1,404
1,886
2,503
1,211
1,133
1,192
1,292
1,807
0
01,8071,2921,1921,1331,2112,5031,8861,4047399089673,2073,0293,0293,0613,2453,2133,2713,2163,2913,28411,561000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
0
0
17,807
0
0
0
23,337
0
0
0
13,099
10,869
7,451
7,285
5,919
2,783
3,206
3,879
4,168
16,569
16,491
15,918
14,817
15,325
13,388
12,067
11,558
10,254
9,545
12,143
14,176
15,152
16,191
14,721
18,521
20,478
18,663
21,115
27,900
24,143
26,920
20,904
17,528
15,854
17,875
18,118
17,540
11,486
14,397
13,732
12,169
10,572
11,526
11,299
13,449
10,877
14,493
19,087
8,688
6,871
10,215
11,023
14,289
13,324
17,807
18,997
13,418
3,760
920
632
572
406
469
532
552
499
556
761
204,264
196,128
183,528
155,933
147,936
142,864
141,648
134,815
141,472
136,916
123,257
137,149
134,657
129,274
126,274
119,214
115,169
111,495
122,229
118,889
116,334
115,264
115,382
113,426
111,363
111,363113,426115,382115,264116,334118,889122,229111,495115,169119,214126,274129,274134,657137,149123,257136,916141,472134,815141,648142,864147,936155,933183,528196,128204,2647615564995525324694065726329203,76013,41818,99717,80713,32414,28911,02310,2156,8718,68819,08714,49310,87713,44911,29911,52610,57212,16913,73214,39711,48617,54018,11817,87515,85417,52820,90426,92024,14327,90021,11518,66320,47818,52114,72116,19115,15214,17612,1439,54510,25411,55812,06713,38815,32514,81715,91816,49116,5694,1683,8793,2062,7835,9197,2857,45110,86913,09900023,33700017,807000000
   > Total Current Liabilities 
0
0
0
0
0
0
11,178
0
0
0
20,921
0
0
0
9,849
8,656
5,699
5,693
4,612
2,698
3,079
3,879
3,692
7,056
7,228
7,867
7,710
9,003
7,623
7,173
11,456
10,147
9,440
12,142
12,015
13,193
14,215
8,225
14,318
16,934
13,109
12,773
13,814
9,554
14,160
9,150
9,800
8,869
10,730
11,233
14,232
10,052
11,960
11,518
9,842
8,440
9,660
9,768
12,103
9,575
13,451
18,010
7,463
5,764
5,358
6,023
13,787
13,324
17,807
18,997
13,347
3,726
874
580
451
307
359
413
452
388
431
619
34,602
29,603
28,976
38,528
38,268
36,771
39,266
36,301
47,139
48,908
37,936
35,428
35,642
35,096
33,634
29,922
27,672
26,367
39,688
31,175
31,190
30,398
31,533
25,303
26,688
26,68825,30331,53330,39831,19031,17539,68826,36727,67229,92233,63435,09635,64235,42837,93648,90847,13936,30139,26636,77138,26838,52828,97629,60334,6026194313884524133593074515808743,72613,34718,99717,80713,32413,7876,0235,3585,7647,46318,01013,4519,57512,1039,7689,6608,4409,84211,51811,96010,05214,23211,23310,7308,8699,8009,15014,1609,55413,81412,77313,10916,93414,3188,22514,21513,19312,01512,1429,44010,14711,4567,1737,6239,0037,7107,8677,2287,0563,6923,8793,0792,6984,6125,6935,6998,6569,84900020,92100011,178000000
       Short-term Debt 
0
0
0
0
0
0
1,430
0
0
0
7,388
0
0
0
3,668
4,473
2,652
2,744
1,943
172
180
172
174
167
0
2,758
3,043
3,048
2,886
3,011
6,981
6,545
0
6,947
2,110
2,119
2,036
2,927
7,452
8,779
3,367
0
2,170
2,247
0
2,197
2,099
2,207
2,600
3,045
6,590
401
381
370
390
0
448
424
333
242
139
36
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,000
5,398
5,404
5,452
6,043
6,624
7,241
9,341
10,142
11,006
11,728
12,578
12,606
12,595
12,560
14,884
13,584
12,798
0
0
0
00012,79813,58414,88412,56012,59512,60612,57811,72811,00610,1429,3417,2416,6246,0435,4525,4045,3985,0000000000000000000000000003613924233342444803903703814016,5903,0452,6002,2072,0992,19702,2472,17003,3678,7797,4522,9272,0362,1192,1106,94706,5456,9813,0112,8863,0483,0432,75801671741721801721,9432,7442,6524,4733,6680007,3880001,430000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,000
5,000
5,000
5,000
5,625
6,250
6,875
9,000
9,750
10,500
11,250
12,000
12,000
12,000
12,000
14,306
13,056
12,306
12,056
4,692
4,692
4,6924,69212,05612,30613,05614,30612,00012,00012,00012,00011,25010,5009,7509,0006,8756,2505,6255,0005,0005,0005,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
8,969
0
0
0
13,395
0
0
0
4,049
4,115
2,881
2,655
2,669
2,698
3,079
3,879
3,692
4,671
4,630
5,109
4,667
5,956
4,737
4,162
4,475
3,603
4,303
4,976
7,983
10,246
11,517
5,211
6,866
8,155
9,742
9,942
10,488
7,307
11,162
6,507
7,702
0
0
0
0
0
11,345
11,055
8,167
6,881
7,150
6,957
8,155
8,755
12,501
16,702
6,235
5,150
5,186
5,431
5,389
4,293
5,739
6,148
5,146
2,134
607
561
433
290
345
401
440
376
422
609
12,596
11,029
10,911
12,861
12,405
10,591
13,393
11,907
13,466
22,087
15,315
14,565
14,223
16,126
9,482
11,093
9,316
9,633
12,837
12,103
11,591
13,238
12,925
14,011
14,107
14,10714,01112,92513,23811,59112,10312,8379,6339,31611,0939,48216,12614,22314,56515,31522,08713,46611,90713,39310,59112,40512,86110,91111,02912,5966094223764404013452904335616072,1345,1466,1485,7394,2935,3895,4315,1865,1506,23516,70212,5018,7558,1556,9577,1506,8818,16711,05511,345000007,7026,50711,1627,30710,4889,9429,7428,1556,8665,21111,51710,2467,9834,9764,3033,6034,4754,1624,7375,9564,6675,1094,6304,6713,6923,8793,0792,6982,6692,6552,8814,1154,04900013,3950008,969000000
       Other Current Liabilities 
0
0
0
0
0
0
780
0
0
0
138
0
0
0
2,132
68
166
294
0
-172
-180
-172
0
2,385
2,598
0
0
0
0
0
0
0
5,137
219
1,922
828
662
87
0
0
0
2,831
1,156
0
2,998
446
0
6,662
8,130
8,188
7,642
9,651
233
92
1,286
1,559
2,062
2,387
3,615
578
811
1,272
1,227
614
171
592
8,398
9,031
12,068
12,849
8,201
1,592
267
19
18
17
14
12
12
12
9
10
22,006
18,574
18,065
25,667
20,863
20,782
20,469
18,942
27,630
20,197
15,380
11,522
11,277
7,964
12,424
6,251
5,750
4,139
14,291
4,188
6,015
4,362
6,089
1,839
1,720
1,7201,8396,0894,3626,0154,18814,2914,1395,7506,25112,4247,96411,27711,52215,38020,19727,63018,94220,46920,78220,86325,66718,06518,57422,006109121212141718192671,5928,20112,84912,0689,0318,3985921716141,2271,2728115783,6152,3872,0621,5591,286922339,6517,6428,1888,1306,66204462,99801,1562,831000876628281,9222195,13700000002,5982,3850-172-180-1720294166682,132000138000780000000
   > Long-term Liabilities 
0
0
0
0
0
0
6,629
0
0
0
2,417
0
0
0
3,250
2,213
1,751
1,592
1,306
85
127
4,052
476
9,513
9,262
8,051
7,107
6,322
5,765
4,894
101
107
105
1
2,161
1,959
1,976
6,497
4,203
3,544
5,555
8,342
14,086
14,589
12,760
11,754
7,727
6,985
7,145
6,885
3,308
1,434
2,437
2,215
2,327
2,132
1,866
1,531
1,346
1,302
1,042
1,077
1,225
1,107
4,858
5,000
502
4,293
5,739
6,148
71
34
46
52
121
99
111
119
100
111
125
142
169,662
166,525
154,552
117,405
109,668
106,093
102,382
98,514
94,333
88,008
85,321
101,721
99,015
94,178
92,640
89,292
87,497
85,128
82,541
87,714
85,144
84,866
83,849
88,123
84,675
84,67588,12383,84984,86685,14487,71482,54185,12887,49789,29292,64094,17899,015101,72185,32188,00894,33398,514102,382106,093109,668117,405154,552166,525169,66214212511110011911199121524634716,1485,7394,2935025,0004,8581,1071,2251,0771,0421,3021,3461,5311,8662,1322,3272,2152,4371,4343,3086,8857,1456,9857,72711,75412,76014,58914,0868,3425,5553,5444,2036,4971,9761,9592,16111051071014,8945,7656,3227,1078,0519,2629,5134764,052127851,3061,5921,7512,2133,2500002,4170006,629000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91,117
89,915
88,827
87,067
85,089
83,320
99,734
96,981
93,960
91,104
87,453
84,960
82,034
79,074
84,819
83,761
82,399
81,555
85,469
0
085,46981,55582,39983,76184,81979,07482,03484,96087,45391,10493,96096,98199,73483,32085,08987,06788,82789,91591,117000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,780
17,095
15,671
12,718
10,211
7,497
5,078
948
85,321
0
0
218
1,536
1,839
2,537
3,094
3,467
2,895
1,383
0
2,294
0
0
002,29401,3832,8953,4673,0942,5371,8391,5362180085,3219485,0787,49710,21112,71815,67117,09526,780000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
10,008
0
0
0
14,223
0
0
0
12,477
12,089
25,301
24,840
24,454
24,689
25,969
24,830
24,468
25,944
26,369
26,528
26,674
27,298
27,292
27,703
18,421
18,896
20,791
21,999
30,019
30,290
31,897
31,946
30,724
32,284
36,814
40,207
50,092
49,026
50,553
48,749
28,334
26,662
30,924
32,532
35,898
36,486
38,593
33,390
33,234
36,613
34,469
30,627
32,561
35,901
38,573
42,290
40,991
42,465
40,011
41,283
40,526
40,884
42,746
43,153
46,752
41,513
42,125
27,416
26,027
26,817
26,532
25,878
24,972
24,902
25,285
26,184
180,382
189,719
184,530
166,866
158,489
156,956
193,070
188,543
178,199
169,492
168,576
168,843
169,249
167,458
169,830
164,699
160,736
159,029
144,399
131,446
125,318
118,891
111,436
101,802
97,697
97,697101,802111,436118,891125,318131,446144,399159,029160,736164,699169,830167,458169,249168,843168,576169,492178,199188,543193,070156,956158,489166,866184,530189,719180,38226,18425,28524,90224,97225,87826,53226,81726,02727,41642,12541,51346,75243,15342,74640,88440,52641,28340,01142,46540,99142,29038,57335,90132,56130,62734,46936,61333,23433,39038,59336,48635,89832,53230,92426,66228,33448,74950,55349,02650,09240,20736,81432,28430,72431,94631,89730,29030,01921,99920,79118,89618,42127,70327,29227,29826,67426,52826,36925,94424,46824,83025,96924,68924,45424,84025,30112,08912,47700014,22300010,008000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,201
43,464
41,392
41,449
39,772
38,311
21,529
20,578
19,786
18,117
18,398
22,150
21,304
22,140
22,090
21,622
21,103
21,270
21,810
22,859
192,743
211,482
211,148
210,360
210,360
210,360
245,313
245,314
248,687
256,250
256,283
256,292
257,411
259,825
263,275
265,561
265,917
266,129
266,007
265,629
265,206
265,165
264,761
263,586
0
0263,586264,761265,165265,206265,629266,007266,129265,917265,561263,275259,825257,411256,292256,283256,250248,687245,314245,313210,360210,360210,360211,148211,482192,74322,85921,81021,27021,10321,62222,09022,14021,30422,15018,39818,11719,78620,57821,52938,31139,77241,44941,39243,46444,20100000000000000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-5,589
0
0
0
-7,526
0
0
0
-4,081
-3,883
-4,043
0
-4,185
-4,177
-4,393
-4,198
-4,918
13
-2,574
-1,729
-2,273
-2,136
-2,195
-3,367
-4,116
-3,933
-4,011
-4,682
-4,764
-4,858
-5,409
-5,463
-5,249
-5,345
-6,053
-7,313
50,092
-6,732
-6,829
48,749
-4,607
0
-5,211
-5,773
-5,307
0
-120
0
-305
-315
-116
-43
19
149
360
-61
-21
-21
-20
-20
-20
-31,265
26
22
-2,261
0
0
0
8
8
9
8
8
8
8
9
5,941
1,321
-2,247
523
-7,455
-4,497
-1,287
-3,135
-537
-14,581
-8,275
-5,365
2,020
3,463
6,200
2,161
2,959
5,397
973
-6,605
-5,260
-5,167
0
0
0
000-5,167-5,260-6,6059735,3972,9592,1616,2003,4632,020-5,365-8,275-14,581-537-3,135-1,287-4,497-7,455523-2,2471,3215,94198888988000-2,2612226-31,265-20-20-20-21-21-6136014919-43-116-315-3050-1200-5,307-5,773-5,2110-4,60748,749-6,829-6,73250,092-7,313-6,053-5,345-5,249-5,463-5,409-4,858-4,764-4,682-4,011-3,933-4,116-3,367-2,195-2,136-2,273-1,729-2,57413-4,918-4,198-4,393-4,177-4,1850-4,043-3,883-4,081000-7,526000-5,589000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,207
13,956
14,434
11,517
10,301
10,690
10,972
11,393
11,772
11,474
11,377
11,717
12,264
12,625
13,325
13,821
14,281
14,151
14,175
0
014,17514,15114,28113,82113,32512,62512,26411,71711,37711,47411,77211,39310,97210,69010,30111,51714,43413,95613,207000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
20,732
0
0
0
19,125
0
0
0
15,271
14,530
29,618
24,961
28,776
28,908
30,483
29,158
25,162
27,023
29,472
29,793
31,144
30,800
30,293
32,022
33,595
33,385
34,759
36,677
36,721
36,583
38,279
38,199
36,594
36,976
40,072
42,966
0
48,502
49,050
0
40,834
34,934
42,913
46,667
47,698
36,486
47,560
33,390
45,051
46,416
46,635
43,526
44,238
45,300
44,460
45,729
960
693
670
683
662
638
18,825
17,994
17,301
15,842
16,090
525
508
543
545
536
525
529
542
568
12,330
12,424
11,690
12,725
12,973
13,207
13,956
14,434
11,517
10,301
10,690
10,972
11,393
11,772
11,474
11,377
11,717
12,264
12,625
13,325
13,821
14,281
-2,870
-5,024
0
0-5,024-2,87014,28113,82113,32512,62512,26411,71711,37711,47411,77211,39310,97210,69010,30111,51714,43413,95613,20712,97312,72511,69012,42412,33056854252952553654554350852516,09015,84217,30117,99418,82563866268367069396045,72944,46045,30044,23843,52646,63546,41645,05133,39047,56036,48647,69846,66742,91334,93440,834049,05048,502042,96640,07236,97636,59438,19938,27936,58336,72136,67734,75933,38533,59532,02230,29330,80031,14429,79329,47227,02325,16229,15830,48328,90828,77624,96129,61814,53015,27100019,12500020,732000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue63,074
Cost of Revenue-7,624
Gross Profit55,45055,450
 
Operating Income (+$)
Gross Profit55,450
Operating Expense-73,423
Operating Income-10,349-17,973
 
Operating Expense (+$)
Research Development-
Selling General Administrative28,286
Selling And Marketing Expenses-
Operating Expense73,42328,286
 
Net Interest Income (+$)
Interest Income350
Interest Expense-8,748
Other Finance Cost-0
Net Interest Income-8,398
 
Pretax Income (+$)
Operating Income-10,349
Net Interest Income-8,398
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-27,803-1,293
EBIT - interestExpense = -8,748
-27,531
-18,783
Interest Expense8,748
Earnings Before Interest and Taxes (EBIT)--19,055
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-27,803
Tax Provision--272
Net Income From Continuing Ops-27,531-27,531
Net Income-27,531
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-9,0568,398
 

Technical Analysis of HLS Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of HLS Therapeutics Inc. The general trend of HLS Therapeutics Inc is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine HLS Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of HLS Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.38 < 5.48 < 5.52.

The bearish price targets are: 4.5 > 4.47 > 3.52.

Tweet this
HLS Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of HLS Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

HLS Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of HLS Therapeutics Inc. The current macd is 0.26210431.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the HLS Therapeutics Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for HLS Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the HLS Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
HLS Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartHLS Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of HLS Therapeutics Inc. The current adx is 42.03.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy HLS Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
HLS Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of HLS Therapeutics Inc. The current sar is 4.46842105.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
HLS Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of HLS Therapeutics Inc. The current rsi is 63.27. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
HLS Therapeutics Inc Daily Relative Strength Index (RSI) ChartHLS Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of HLS Therapeutics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HLS Therapeutics Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
HLS Therapeutics Inc Daily Stochastic Oscillator ChartHLS Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of HLS Therapeutics Inc. The current cci is 64.05.

HLS Therapeutics Inc Daily Commodity Channel Index (CCI) ChartHLS Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of HLS Therapeutics Inc. The current cmo is 26.17.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
HLS Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartHLS Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of HLS Therapeutics Inc. The current willr is -30.93922652.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that HLS Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
HLS Therapeutics Inc Daily Williams %R ChartHLS Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of HLS Therapeutics Inc.

HLS Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of HLS Therapeutics Inc. The current atr is 0.2304788.

HLS Therapeutics Inc Daily Average True Range (ATR) ChartHLS Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of HLS Therapeutics Inc. The current obv is -2,995,405.

HLS Therapeutics Inc Daily On-Balance Volume (OBV) ChartHLS Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of HLS Therapeutics Inc. The current mfi is 60.06.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
HLS Therapeutics Inc Daily Money Flow Index (MFI) ChartHLS Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for HLS Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

HLS Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of HLS Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.270
Ma 20Greater thanMa 504.392
Ma 50Greater thanMa 1004.225
Ma 100Greater thanMa 2004.035
OpenGreater thanClose4.900
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of HLS Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on HLS Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about HLS Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about HLS Therapeutics Inc

I send you an email if I find something interesting about HLS Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about HLS Therapeutics Inc.

Receive notifications about HLS Therapeutics Inc in your mailbox!